Item 8.01 Other Events
On May 23, 2022, Exela Technologies, Inc., a Delaware corporation (the
"Company"), launched an offering for the sale of shares of the Company's common
stock, par value $0.0001 per share, having an aggregate offering price of up to
$250,000,000 (the "Shares"). The Shares will be sold pursuant to the At Market
Issuance Sales Agreement, dated September 30, 2021 (the "Sales Agreement"),
between the Company and B. Riley Securities, Inc., Cantor Fitzgerald & Co.,
Mizuho Securities USA LLC and Needham & Company, LLC (each, an "Agent" and,
together, the "Agents").
The Shares are in addition to the shares of the Company's common stock that have
previously been offered and sold under the Sales Agreement.
The Company is not obligated to sell any of the Shares under the Sales
Agreement. Subject to the terms and conditions of the Sales Agreement, the
Agents will use commercially reasonable efforts, consistent with their
respective normal trading and sales practices and applicable state and federal
laws, rules and regulations and the rules of the Nasdaq Stock Market LLC, to
sell the Shares from time to time based upon the Company's instructions,
including any price, time or size limits specified by the Company. Pursuant to
the Sales Agreement, the Agents may sell the Shares by any method permitted by
law deemed to be an "at the market offering" under Rule 415(a)(4) under the
Securities Act of 1933, as amended. The Company will pay the applicable agent a
commission at a fixed commission rate of up to 5.0% of the gross proceeds from
each sale of the Shares and provide the Agents with customary indemnification
and contribution rights. The Sales Agreement may be terminated by the applicable
Agent with respect to itself or the Company at any time upon five (5) days'
notice to the other party.
The issuance and sale, if any, of the Shares by the Company under the Sales
Agreement will be made pursuant to the Company's effective registration
statement on Form S-3 (Registration Statement No. 333-263909) (the "Registration
Statement") filed with the U.S. Securities and Exchange Commission (the "SEC")
on March 28, 2022 and declared effective on May 10, 2022, as supplemented by the
prospectus supplement, dated May 23, 2022, as filed with the SEC on May 23,
2022. The foregoing description of the Sales Agreement does not purport to be
complete and is qualified in its entirety by reference to the full text of the
Sales Agreement, a copy of which is incorporated by reference to the Current
Report on Form 8-K filed by the Company with the SEC on September 30, 2021 and
is incorporated herein by reference. The legal opinion of Paul, Weiss, Rifkind,
Wharton & Garrison LLP, counsel to the Company, relating to the validity of the
Shares being offered pursuant to the Sales Agreement is filed as Exhibit 5.1 to
this Current Report on Form 8-K and is incorporated herein by reference.
This Current Report on Form 8-K shall not constitute an offer to sell or the
solicitation of an offer to buy any of the Shares under the Sales Agreement nor
shall there be any sale of the Shares in any state in which such offer,
solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number Description
1.1 At Market Issuance Sales Agreement, dated September 30, 2021, by and
among Exela Technologies, Inc. and B. Riley Securities, Inc., BNP
Paribas Securities Corp., Cantor Fitzgerald & Co., Mizuho Securities
USA LLC and Needham & Company, LLC (incorporated by reference to the
Current Report on Form 8-K filed by Exela Technologies, Inc. with the
SEC on September 30, 2021).
5.1 Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP.
23.1 Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in
Exhibit 5.1).
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
© Edgar Online, source Glimpses